Response to first-line erlotinib in a false EGFR mutation-negative patient with non-small-cell lung cancer: Make no assumptions
Crossref DOI link: https://doi.org/10.17352/ojcps.000001
Published Online: 2018-10-01
Update policy: https://doi.org/10.17352/crossmark-policy
Deng, Caixia
Luo, Hu
Zhou, Xiangdong
Version of Record valid from 2013-11-25
Accepted Manuscript valid from 2015-05-25